ArticleScientific reports2025

Novel fully human IgG1 targeting folate receptor α demonstrates antitumor efficacy driven by avidity rather than monovalent binding affinity.

Elena Pinto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.